vs

Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and MACERICH CO (MAC). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($269.1M vs $261.7M, roughly 1.0× MACERICH CO). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs -7.2%, a 57.7% gap on every dollar of revenue. On growth, Inspire Medical Systems, Inc. posted the faster year-over-year revenue change (12.2% vs -4.4%). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs 12.0%).

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

The Macerich Company is a real estate investment trust that invests in shopping centers. It is the third-largest owner and operator of shopping centers in the United States. As of December 31, 2024, the company owned interests in 43 properties comprising 43 million square feet of leasable area. The company name is a portmanteau of its founders, Mace Siegel and Richard Cohen.

INSP vs MAC — Head-to-Head

Bigger by revenue
INSP
INSP
1.0× larger
INSP
$269.1M
$261.7M
MAC
Growing faster (revenue YoY)
INSP
INSP
+16.6% gap
INSP
12.2%
-4.4%
MAC
Higher net margin
INSP
INSP
57.7% more per $
INSP
50.6%
-7.2%
MAC
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
12.0%
MAC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INSP
INSP
MAC
MAC
Revenue
$269.1M
$261.7M
Net Profit
$136.1M
$-18.8M
Gross Margin
86.6%
Operating Margin
17.1%
Net Margin
50.6%
-7.2%
Revenue YoY
12.2%
-4.4%
Net Profit YoY
286.4%
91.1%
EPS (diluted)
$4.57
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSP
INSP
MAC
MAC
Q4 25
$269.1M
$261.7M
Q3 25
$224.5M
$253.3M
Q2 25
$217.1M
$249.8M
Q1 25
$201.3M
$249.2M
Q4 24
$239.7M
$273.7M
Q3 24
$203.2M
$220.2M
Q2 24
$195.9M
$215.5M
Q1 24
$164.0M
$208.8M
Net Profit
INSP
INSP
MAC
MAC
Q4 25
$136.1M
$-18.8M
Q3 25
$9.9M
$-87.4M
Q2 25
$-3.6M
$-40.9M
Q1 25
$3.0M
$-50.1M
Q4 24
$35.2M
$-211.2M
Q3 24
$18.5M
$-108.2M
Q2 24
$9.8M
$252.0M
Q1 24
$-10.0M
$-126.7M
Gross Margin
INSP
INSP
MAC
MAC
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Q1 24
84.9%
Operating Margin
INSP
INSP
MAC
MAC
Q4 25
17.1%
Q3 25
4.3%
Q2 25
-1.5%
Q1 25
-0.7%
Q4 24
13.3%
Q3 24
7.0%
Q2 24
2.6%
Q1 24
-9.3%
Net Margin
INSP
INSP
MAC
MAC
Q4 25
50.6%
-7.2%
Q3 25
4.4%
-34.5%
Q2 25
-1.7%
-16.4%
Q1 25
1.5%
-20.1%
Q4 24
14.7%
-77.2%
Q3 24
9.1%
-49.1%
Q2 24
5.0%
116.9%
Q1 24
-6.1%
-60.7%
EPS (diluted)
INSP
INSP
MAC
MAC
Q4 25
$4.57
$-0.08
Q3 25
$0.34
$-0.34
Q2 25
$-0.12
$-0.16
Q1 25
$0.10
$-0.20
Q4 24
$1.17
$-0.95
Q3 24
$0.60
$-0.50
Q2 24
$0.32
$1.16
Q1 24
$-0.34
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSP
INSP
MAC
MAC
Cash + ST InvestmentsLiquidity on hand
$308.3M
$280.2M
Total DebtLower is stronger
$5.1B
Stockholders' EquityBook value
$781.2M
$2.4B
Total Assets
$907.3M
$8.4B
Debt / EquityLower = less leverage
2.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSP
INSP
MAC
MAC
Q4 25
$308.3M
$280.2M
Q3 25
$322.6M
$290.2M
Q2 25
$300.9M
$131.1M
Q1 25
$369.2M
$253.2M
Q4 24
$445.5M
$89.9M
Q3 24
$411.0M
$116.5M
Q2 24
$439.7M
$70.7M
Q1 24
$441.4M
$120.1M
Total Debt
INSP
INSP
MAC
MAC
Q4 25
$5.1B
Q3 25
$5.1B
Q2 25
$5.2B
Q1 25
$5.2B
Q4 24
$4.9B
Q3 24
$4.3B
Q2 24
$4.4B
Q1 24
$4.1B
Stockholders' Equity
INSP
INSP
MAC
MAC
Q4 25
$781.2M
$2.4B
Q3 25
$666.5M
$2.5B
Q2 25
$677.8M
$2.6B
Q1 25
$635.7M
$2.7B
Q4 24
$689.7M
$2.8B
Q3 24
$696.6M
$2.5B
Q2 24
$638.1M
$2.5B
Q1 24
$589.0M
$2.3B
Total Assets
INSP
INSP
MAC
MAC
Q4 25
$907.3M
$8.4B
Q3 25
$807.7M
$8.4B
Q2 25
$802.2M
$8.7B
Q1 25
$730.8M
$8.7B
Q4 24
$808.4M
$8.6B
Q3 24
$796.2M
$7.6B
Q2 24
$728.4M
$7.8B
Q1 24
$685.8M
$7.4B
Debt / Equity
INSP
INSP
MAC
MAC
Q4 25
2.07×
Q3 25
2.02×
Q2 25
2.02×
Q1 25
1.96×
Q4 24
1.78×
Q3 24
1.73×
Q2 24
1.75×
Q1 24
1.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSP
INSP
MAC
MAC
Operating Cash FlowLast quarter
$52.5M
$50.2M
Free Cash FlowOCF − Capex
$41.8M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$78.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSP
INSP
MAC
MAC
Q4 25
$52.5M
$50.2M
Q3 25
$68.5M
$112.4M
Q2 25
$2.7M
$70.5M
Q1 25
$-6.7M
$88.5M
Q4 24
$69.2M
$54.9M
Q3 24
$52.3M
$100.0M
Q2 24
$-78.0K
$67.4M
Q1 24
$8.9M
$61.1M
Free Cash Flow
INSP
INSP
MAC
MAC
Q4 25
$41.8M
Q3 25
$58.1M
Q2 25
$-6.3M
Q1 25
$-15.1M
Q4 24
$62.2M
Q3 24
$44.3M
Q2 24
$-12.5M
Q1 24
$-2.8M
FCF Margin
INSP
INSP
MAC
MAC
Q4 25
15.5%
Q3 25
25.9%
Q2 25
-2.9%
Q1 25
-7.5%
Q4 24
25.9%
Q3 24
21.8%
Q2 24
-6.4%
Q1 24
-1.7%
Capex Intensity
INSP
INSP
MAC
MAC
Q4 25
4.0%
Q3 25
4.6%
Q2 25
4.1%
Q1 25
4.2%
Q4 24
2.9%
Q3 24
3.9%
Q2 24
6.3%
Q1 24
7.1%
Cash Conversion
INSP
INSP
MAC
MAC
Q4 25
0.39×
Q3 25
6.90×
Q2 25
Q1 25
-2.24×
Q4 24
1.96×
Q3 24
2.83×
Q2 24
-0.01×
0.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons